Dawson MA et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 478, 529-533 (2011)

Bantscheff M et al. Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nature Biotechnology 29, 255-265 (2011)

Huang S et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461, 614-620 (2009)

Bantscheff M et al. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nature Biotechnology 25, 1035-1044 (2007)

Mallick P et al. Computational prediction of proteotypic peptides for quantitative proteomics. Nature Biotechnology 25, 125-131 (2007)

Gavin AC et al. Proteome survey reveals modularity of the yeast cell machinery. Nature 440, 631-636 (2006)

Bouwmeester T et al. A physical and functional map of the human TNF-α/NF-κB signal transduction pathway. Nature Cell Biology 6, 97-105 (2004)

Gavin AC et al. Functional Organization of the Yeast Proteome by Systematic Analysis of Protein Complexes. Nature 415, 141-147 (2002)

Schirle M, Bantscheff M, Kuster B. Mass spectrometry-based proteomics in preclinical drug discovery. Chem Biol. 19 (1), 72-84 (2012)

Haupt A et al. Hsp90 inhibition differentially destabilises MAP kinase and TGF-beta signalling components in cancer cells revealed by kinase-targeted chemoproteomics. BMC Cancer (2012), 12:38 doi:10.1186/1471-2407-12-38, Published: 25 January 2012

Drewes G. Future strategies in epigenetic drug discovery, Drug Discov Today: Ther Strategies (2011), doi:10.1016/j.ddstr.2011.12.001

Bantscheff M, Drewes G. Chemoproteomic approaches to drug target identification and drug profiling. Bioorg Med Chem 2011 Nov 9. [Epub ahead of print]

Ramsden N et al. Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson's disease-related toxicity in human neurons. ACS Chemical Biology 6 (10), 1021-8 (2011)

Perino A et al. Integrating Cardiac PIP(3) and cAMP Signaling through a PKA Anchoring Function of p110γ. Mol Cell. 42 (1), 84-95 (2011)

Gauthier-Kemper A et al. The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner. J Cell Biol. 192 (4), 647-61 (2011)

Eschenhagen T et al. Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 13 (1), 1-10 (2011)

Van Broeck B et al. Chronic treatment with a novel γ-secretase modulator, JNJ-40418677, inhibits amyloid plaque formation in a mouse model of Alzheimer's disease. Br J Pharmacol. 163 (2), 375-89 (2011)

Savitski MM et al. Confident phosphorylation site localization using the Mascot Delta Score. Mol. Cell Proteomics 10 (2), M110.003830. (2011)

Jagani Z et al. Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway. Nat. Med. 16 (12), 1429-33 (2010)

Savitski MM, Mathieson T, Becher I, Bantscheff M. H-score, a mass accuracy driven rescoring approach for improved peptide identification in modification rich samples. J Proteome Res. 9 (11), 5511-6 (2010)

Kruse U et al. Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells. Leukemia 25 (1), 89-100 (2011)

Savitski MM et al Evaluation of Data Analysis Strategies for Improved Mass Spectrometry-Based Phosphoproteomics. Anal. Chem. 82 (23), 9843-9 (2010)

Cramp S et al. Identification and hit-to-lead exploration of a novel series of histamine H4 receptor inverse agonists. Bioorg Med Chem Lett. 20 (8), 2516-9 (2010)

Gaither LA et al. Multiple cyclophilins involved in different cellular pathways mediate HCV replication. Virology 5 (397), 43-55 (2010)

Savitski MM et al. Targeted data acquisition for improved reproducibility and robustness of proteomic mass spectrometry assays. J. Am. Soc. Mass Spectrom. 21, 1668-1679 (2010)

Holson EB, Schreiber SL. Chemoproteomics quantifies complexity. Nat Biotechnol. 29, 235-6 (2011)

Peters EC, Gray NS. Chemical proteomics identifies unanticipated targets of clinical kinase inhibitors. ACS Chemical Biology 2, 661-644 (2007)

White FM. On the iTRAQ of kinase inhibitors. Nature Biotechnology 25, 994-996 (2007)

von Mering C et al. Comparative Assessment of Large-Scale Data Sets of Protein-Protein Interactions. Nature 417, 399-403 (2002)

Edwards AM et al. Bridging structural biology and genomics: assessing protein interaction data with known complexes. Trends in Genetics 18, 529-536 (2002)

Kemmeren P et al. Protein Interaction Verification and Functional Annotation by Integrated Analysis of Genome- Scale Data. Molecular Cell 9, 1133-1143 (2002)

Bader GD, Hogue CW. Analyzing yeast protein-protein interaction data obtained from different sources. Nature Biotechnology 20, 991-997 (2002)

Bantscheff M, Scholten A, Heck AJ. Revealing promiscuous drug-target interactions by chemical proteomics. Drug Discovery Today, 14 (21-22), 1021-9 (2009)

Ratcliffe AJ. Medicinal chemistry strategies to minimize phospholipidosis. Curr. Med. Chem. 16, 2816-2823 (2009)

Borawski J et al. Class III phosphatidylinositol 4-kinase alpha and beta are novel host factor regulators of hepatitis C virus replication. J Virol. 83 (19), 10058-74 (2009)

Heymans S et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure 11, 119-129 (2009)

Winkler E et al. Purification, Pharmacological Modulation, and Biochemical Characterization of Interactors of Endogenous Human gamma-Secretase (dagger). Biochemistry 48, 1183-97 (2009)

Marwick JA et al. Oxidative stress modulates theophylline effects on steroid responsiveness. Biochemical and Biophysical Research Communications 377, 797-802 (2008)

Kruse U et al. Chemical and pathway proteomics: Powerful tools for oncology drug discovery and personalized health care. Mol Cell Proteomics 7, 1887-1901 (2008)

Bantscheff, M et al. Robust and sensitive iTRAQ quantification on an LTQOrbitrap mass spectrometer. Mol Cell Proteomics 7, 1702-1713 (2008)

Mathivanan S et al. Human Proteinpedia enables sharing of human protein data. Nat. Biotechnol. 26, 164-167 (2008)

Bantscheff M et al. Quantitative mass spectrometry in proteomics: a critical review. Analytical and Bioanalytical Chemistry 389, 1017-1031 (2007)

Hopf C, Bantscheff M and Drewes G. Pathway proteomics and chemical proteomics team up in drug discovery. Neurodegenerative Diseases 4, 270-280 (2007)

Fernandez-Montalvan A et al. Biochemical characterization of USP7 reveals post-translational modification sites and structural requirements for substrate processing and subcellular localization. FEBS J. 274, 4256-4270 (2007)

Ruffner H, Bauer A, Bouwmeester T. Human protein-protein interaction networks and the value for drug discovery. Drug Discovery Today 12, 709-716 (2007)

Angrand PO et al. Transgenic mouse proteomics identifies new 14-3-3 associated proteins involved in cytoskeletal rearrangements and cell signalling. Molecular & Cellular Proteomics 5, 2211-2227 (2006)

Chen YM et al. Microtubule affinity-regulating kinase 2 functions downstream of the PAR-3/PAR-6/atypical PKC complex in regulating hippocampal neuronal polarity. Proc. Natl Acad. Sci. USA 103, 8534-8539 (2006)

Simmons DL. What makes a good anti-inflammatory drug target? What makes a good anti-inflammatory drug target? Drug Discovery Today 11, 210-219 (2006)

Neubauer G. The analysis of multiprotein complexes: the yeast and the human spliceosome as case studies. Methods Enzymol. 405, 236-263 (2005)

Mukherjee, A et al. Regulation of Notch signalling by non-visual beta-arrestin. Nature Cell Biology 7, 1191-1201 (2005)

Simmons DL, Buckley, CD. Some new and some not so new anti-inflammatory targets. Immunomodulation and Cancer. Current Opinion in Pharmacology 5, 394-397 (2005)

Gavin AC. Keystone symposia: proteomics and bioinformatics and systems and biology. Expert. Rev. Proteomics. 2, 291-293 (2005)

Simmons DL. Anti-adhesion therapies. Current Opinion in Pharmacology 5,
398-404 (2005)

Kuster B et al. Innovation: Scoring proteomes with proteotypic peptide probes. Nature Reviews Molecular Cell Biology 6, 577-583 (2005)

Gagneur J, Casari G. From molecular networks to qualitative cell behavior. FEBS Lett. 579, 1867-1871 (2005)

Drewes G. MARKing tau for tangles and toxicity. Trends in Biochemical Sciences 29, 548-555 (2004)

Gagneur J et al. Modular decomposition of protein-protein interaction networks. Genome Biology 5, R57 (2004)

Aloy P et al. Structure-Based Assembly of Protein Complexes in Yeast. Science 303, 2026-2029 (2004)

Bantscheff M, Dümpelfeld B, Kuster B. Femtomol sensitivity post-digest ¹⁸O labeling for relative quantification of differential protein complex composition. Rapid Communications in Mass Spectrometry 18, 869-876 (2004)

Brajenovic M et al. Comprehensive proteomic analysis of human Par protein complexes reveals an interconnected protein network. Journal of Biological Chemistry 279, 12804-12811 (2004)

Gagneur, J., Klamt, S. Computation of elementary modes: a unifying framework and the new binary approach. BMC. Bioinformatics. 5, 175 (2004)

Krause R et al. Shared components of protein complexes - versatile building blocks or biochemical artefacts? Bioessays 26, 1333-1343 (2004)

Panse VG et al. A proteome-wide approach identifies sumoylated substrate proteins in yeast. J. Biol. Chem. 279, 41346-41351 (2004)

Diella F et al. Phospho.ELM: a database of experimentally verified phosphorylation sites in eukaryotic proteins. BMC. Bioinformatics 5, 79 (2004)

Hermjakob H et al. The HUPO PSI's molecular interaction format - a community standard for the representation of protein interaction data. Nat. Biotechnol. 22, 177-183 (2004)

Trinczek B et al. MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes. Journal of Biological Chemistry 279, 5915-5923 (2004)

Bauer A, Kuster B. Affinity Purification - Mass Spectrometry. Power Tools for the Characterization of Protein Complexes. European Journal of Biochemistry 270, 570-578 (2003)

Brown D, Superti-Furga G. Rediscovering the sweet spot in drug discovery. Drug Discovery Today 8, 1067-1077 (2003)

Drewes G, Nurse P. The protein kinase kin1, the fission yeast orthologue of mammalian MARK/PAR-1, localises to new cell ends after mitosis and is important for bipolar growth. FEBS Letters 554, 45-49 (2003)

Drewes G, Bouwmeester T. Global approaches to protein-protein interactions. Current Opinion in Cell Biology 15, 199-205 (2003)

Gagneur J, Jackson D, Casari, G. Hierarchical analysis of dependency in metabolic networks. Bioinformatics 19, 1027-1034 (2003)

Gavin AC, Superti-Furga G. Protein complexes and proteome organization from yeast to man. Current Opinion in Chemical Biology 7, 21-27 (2003)

Puntervoll P et al. ELM server: A new resource for investigating short functional sites in modular eukaryotic proteins. Nucleic Acids Research 31, 3625-1630 (2003)

Schirle M, Heurtier MA, Kuster B. Profiling Core Proteomes of Human Cell Lines by One-dimensional PAGE and Liquid Chromatography-Tandem Mass Spectrometry. Molecular & Cellular Proteomics 2, 1297-305 (2003)

Jackson DB, Minch E, Munro RE. Bioinformatics. EXS31-69 (2003)

Bantscheff M, Dümpelfeld B, Küster B. An Improved Two-Step Calibration Method for Matix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectra for Proteomics. Letter to the Editor. Rapid Communications in Mass Spectrometry 16, 1892-1895 (2002).

Grandi P et al. 90S Pre-Ribosomes Include the 35S Pre-rRNA, the U3 snoRNP and 40S Subunit Processing Factors but Predominately Lack 60S Synthesis Factors. Molecular Cell 10, 105-115 (2002)

Raida M. Capillary and Nano-LC Coupled with Mass Spectrometry. In: J. Silberring and R. Ekman (Eds.) Mass Spectrometry and Hyphenated Techniques in Neuropeptide Research 109-134 (2002) New York, Wiley [no abstract available]

Aloy P et al. A Complex prediction: three-dimensional model of the yeast exosome. EMBO reports 3, 628-635 (2002)

Reina J et al. Computer-Aided Design of a PDZ Domain to Recognise New Target Sequences. Nature Structural & Molecular Biology 9, 621-627 (2002)

Rigaut G et al. A generic protein purification method for protein complex characterization and proteome exploration. Nature Biotechnology 17, 1030-1032 (1999)